Propofol sedation in routine endoscopy: A case series comparing target controlled infusion vs manually controlled bolus concept.

Sarraj, Riad; Theiler, Lorenz; Vakilzadeh, Nima; Krupka, Niklas; Wiest, Reiner (2024). Propofol sedation in routine endoscopy: A case series comparing target controlled infusion vs manually controlled bolus concept. World journal of gastrointestinal endoscopy, 16(1), pp. 11-17. Baishideng Publishing Group 10.4253/wjge.v16.i1.11

[img]
Preview
Text
WJGE-16-11.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (670kB) | Preview

BACKGROUND

Many studies have addressed safety and effectiveness of non-anaesthesiologist propofol sedation (NAPS) for gastrointestinal (GI) endoscopy Target controlled infusion (TCI) is claimed to provide an optimal sedation regimen by avoiding under- or oversedation.

AIM

To assess safety and performance of propofol TCI sedation in comparison with nurse-administered bolus-sedation.

METHODS

Fouty-five patients undergoing endoscopy under TCI propofol sedation were prospectively included from November 2016 to May 2017 and compared to 87 patients retrospectively included that underwent endoscopy with NAPS. Patients were matched for age and endoscopic procedure. We recorded time of sedation and endoscopy, dosage of medication and adverse events.

RESULTS

There was a significant reduction in dose per time of propofol administered in the TCI group, compared to the NAPS group (8.2 ± 2.7 mg/min vs 9.3 ± 3.4 mg/min; P = 0.046). The time needed to provide adequate sedation levels was slightly but significantly lower in the control group (5.3 ± 2.7 min vs 7.7 ± 3.3 min; P < 0.001), nonetheless the total endoscopy time was similar in both groups. No differences between TCI and bolus-sedation was observed for mean total-dosage of propofol rate as well as adverse events.

CONCLUSION

This study indicates that sedation using TCI for GI endoscopy reduces the dose of propofol necessary per minute of endoscopy. This may translate into less adverse events. However, further and randomized trials need to confirm this trend.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine

UniBE Contributor:

Sarraj, Riad, Krupka, Niklas, Wiest, Reiner

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1948-5190

Publisher:

Baishideng Publishing Group

Language:

English

Submitter:

Pubmed Import

Date Deposited:

05 Feb 2024 16:01

Last Modified:

06 Feb 2024 14:14

Publisher DOI:

10.4253/wjge.v16.i1.11

PubMed ID:

38313457

Uncontrolled Keywords:

Adverse event Endoscopy Non-anaesthesiologist propofol sedation Propofol Sedation Target controlled infusion

BORIS DOI:

10.48350/192606

URI:

https://boris.unibe.ch/id/eprint/192606

Actions (login required)

Edit item Edit item
Provide Feedback